We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $133M
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
+9.51%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
AUM
$94.7M
AUM Growth
+$5.36M
Cap. Flow
+$2.1M
Cap. Flow %
2.21%
Top 10 Hldgs %
35.56%
Holding
109
New
5
Increased
19
Reduced
37
Closed
9

Sector Composition

Rank Sector Weight
1 Healthcare 56.9%
2 Technology 21.84%
3 Communication Services 7.13%
4 Industrials 6.74%
5 Consumer Staples 4.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INUV icon
26
Inuvo
INUV
$18M
$1.25M 1.32%
564,308
+7,900
+1% +$26.3K
QUIK icon
27
QuickLogic
QUIK
$260M
$1.22M 1.29%
237,535
-2,500
-1% -$15K
CTLP
28
DELISTED
Cantaloupe
CTLP
$1.2M 1.26%
275,350
+10,000
+4% +$35.5K
GILD icon
29
Gilead Sciences
GILD
$168B
$1.19M 1.25%
13,817
-500
-3% -$39.6K
FPAY
30
DELISTED
FlexShopper
FPAY
$1.19M 1.25%
1,281,460
-3,480
-0.3% -$4.58K
BMY icon
31
Bristol-Myers Squibb
BMY
$135B
$1.13M 1.19%
15,641
TGT icon
32
Target
TGT
$67.3B
$1.11M 1.18%
7,475
-254
-3% -$39.9K
ELUT icon
33
Elutia
ELUT
$38.5M
$1.1M 1.16%
259,079
+40,750
+19% +$255K
PDCO
34
DELISTED
Patterson Companies, Inc.
PDCO
$1M 1.06%
35,770
-180
-0.5% -$4.97K
SKYT
35
DELISTED
SkyWater Technology
SKYT
$995K 1.05%
+140,000
New +$1.18M
VCEL icon
36
Vericel Corp
VCEL
$2.37B
$950K 1%
36,067
-300
-0.8% -$7.14K
CIEN icon
37
Ciena
CIEN
$58.2B
$918K 0.97%
18,000
EGHT icon
38
8x8 Inc
EGHT
$318M
$901K 0.95%
+208,500
New +$838K
CSTL icon
39
Castle Biosciences
CSTL
$953M
$732K 0.77%
31,110
MMM icon
40
3M
MMM
$93.6B
$727K 0.77%
7,250
-90
-1% -$9.18K
T icon
41
AT&T
T
$160B
$722K 0.76%
39,242
CATX icon
42
Perspective Therapeutics
CATX
$342M
$685K 0.72%
277,264
-7,800
-3% -$25.7K
VZ icon
43
Verizon
VZ
$195B
$647K 0.68%
16,417
XGN icon
44
Exagen
XGN
$156M
$606K 0.64%
252,405
-5,050
-2% -$13K
AAPL icon
45
Apple
AAPL
$4.52T
$604K 0.64%
4,650
AKTS
46
DELISTED
Akoustis Technologies Inc
AKTS
$604K 0.64%
214,350
-2,100
-1% -$6.6K
BLFS icon
47
BioLife Solutions
BLFS
$1.59B
$582K 0.61%
32,000
DCI icon
48
Donaldson
DCI
$11.4B
$582K 0.61%
9,884
MDXH icon
49
MDxHealth
MDXH
$22.7M
$561K 0.59%
84,805
-3
-0% -$21
FBIO icon
50
Fortress Biotech
FBIO
$90.4M
$539K 0.57%
54,834
+2,000
+4% +$22.1K

Similar funds

Perkins Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Perkins Capital Management held 109 positions worth $94.7M, up 6% from $89.4M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Perkins Capital Management's Q4 2022 filing shows 5 new, 19 increased, 37 reduced and 9 closed positions. Its largest new stake was SkyWater Technology: 140,000 shares worth $995K. The largest sale was CareDx, an estimated $969K.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 57% a quarter earlier, followed by Technology and Communication Services.

  • Perkins Capital Management's largest Q4 2022 buy was SkyWater Technology: 140,000 shares worth $995K.
  • Perkins Capital Management added most to Augmedix, Inc. Common Stock in Q4 2022, an estimated $1.57M increase.
  • Perkins Capital Management's biggest Q4 2022 reduction was Biolase, Inc., cutting an estimated $124K.
  • Perkins Capital Management fully exited CareDx in Q4 2022, selling an estimated $969K.
  • Perkins Capital Management's ten largest holdings make up 36% of its $94.7M portfolio in Q4 2022.
  • Perkins Capital Management opened 5 new positions and closed 9 in Q4 2022.
  • Perkins Capital Management's portfolio value rose 6% quarter-over-quarter to $94.7M.

Based on Perkins Capital Management's 13F filing for Q4 2022, filed 26 Jan 2023.